⌘K

Login Start Free

Home/Filings/4/0000950170-23-057499

4//SEC Filing

Simon Amy 4

Accession 0000950170-23-057499

CIK 0001745999other

View on SEC.gov Company Profile

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 4:30 PM ET

Size

4.5 KB

Accession

0000950170-23-057499

Insider Transaction Report

Form 4

Period: 2023-10-30

Beam Therapeutics Inc.BEAM

Chief Medical Officer

Transactions

Sale
Common Stock
2023-10-30$18.70/sh−3,448$64,478→ 65,469 total

Footnotes (1)

[F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Beam Therapeutics Inc.

CIK 0001745999

Entity typeother

Related Parties

1

filerCIK 0001963879

Filing Metadata

Form type: 4
Filed: Oct 31, 8:00 PM ET
Accepted: Nov 1, 4:30 PM ET
Size: 4.5 KB

View on SEC.gov